Intensity-modulated radiation therapy: supportive data for prostate cancer.
about
Protons, Photons, and the Prostate - Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer?Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatmentA new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer.Cost implications of the rapid adoption of newer technologies for treating prostate cancerA new view of radiation-induced cancerVolumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapyRacial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer.Surveillance on interfacility differences in dose-prescription policy of intensity-modulated radiation therapy plans for prostate cancer.The relationship between clinical benefit and receipt of curative therapy for prostate cancerGrowth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse.Nomogram to predict rectal toxicity following prostate cancer radiotherapy.Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patientsIntrafraction motion of the prostate during an IMRT session: a fiducial-based 3D measurement with Cone-beam CT.Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospectEmerging technologies in prostate cancer radiation therapy: improving the therapeutic window.Technological advances in radiotherapy for esophageal cancerRobotic prostate biopsy and its relevance to focal therapy of prostate cancer.Recent advances in radiation oncology: intensity-modulated radiotherapy, a clinical perspective.Integral Dose-Based Inverse Optimization May Reduce Side Effects in Radiotherapy of Prostate Carcinoma.Diagnostic performance of initial transperineal 14-core prostate biopsy to detect significant cancer.Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT : Correlation between high-dose bladder volume, margin reduction, and genitourinary toxicity.Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.Clinical and dosimetric predictors of late rectal bleeding of prostate cancer after TomoTherapy intensity modulated radiation therapy.Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancerImplementation of intensity modulated radiotherapy for prostate cancer in a private radiotherapy service in Mexico.Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping.Dosimetric differences in flattened and flattening filter-free beam treatment plans.National survey on image-guided radiotherapy practice in New Zealand.Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?Haralick textural features on T2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer.Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol.Image-guided radiotherapy for prostate cancerIntensity-modulated radiotherapy for prostate cancer
P2860
Q26767399-D1E10B95-9D2F-42EE-B645-5F3864B576E4Q26849735-FB6BC202-5F66-497F-BA4C-B82FB6952A6AQ33514222-71C7F13E-7A56-4415-A482-2B94F83FD5BBQ34866179-29F964F0-F5DB-49FE-8360-CEBD3FAF0E4BQ35025173-04F170CA-E4A3-4BDA-875A-81D72ADF4CEDQ35111353-D044ACD9-7BDC-41C1-913A-3F4454F39687Q36062411-65D5742E-48C1-42CF-A25A-8C7EC60A8130Q36086196-EA09E9E0-C6B8-4D15-B844-03A7C6A0A19CQ36379715-48B2F89D-0212-4B43-8709-EB568C58ECEDQ36406313-755D099C-8E6C-41FE-A1A2-B598F1E61515Q36412497-1DBB0BCB-3361-403B-9074-522E46CDBBB8Q36507549-3882A19C-E7BB-4A1A-BADB-D02C0E2B997AQ36726326-0502E6BA-00B9-4C26-9E9F-F887032BF5A0Q36987015-7B0F05A1-4A76-4DFC-B63E-DA9F44713A6DQ37528968-EF614FD8-F257-400E-8B33-D46B4C91DE6CQ37791392-BA94AB7C-0E48-48CA-916B-1917661B66E7Q37812088-3ABD83F5-5BF6-4971-96A4-3FE5F51C20DFQ37935525-696E66A9-0A8C-4366-A276-D3A165C351A6Q38225041-0A371AAB-2DB4-4125-977C-56C1EF2AA540Q38904590-10A35D41-76BC-4177-80B8-5AA2F8D413FFQ40100774-B757BA16-2EAC-4B23-B4FF-B8053E83EB83Q40131808-A74270C3-0E0F-4FA9-AB4D-3BA2DFF0BFC9Q40927190-FC0BCCB2-647C-478D-BEA5-A12438639F16Q41633588-22B8029F-CEB3-4738-AEA9-186C4DC9C05EQ41848042-1FC9ABEA-23B2-499D-8511-5A5AC7FE1E9EQ41868843-67F11726-4EE2-454E-9783-7420B3ED225CQ41915810-9CA28C28-533D-43B6-920F-F709B199EE09Q42780109-48D2C3F8-D0C7-4439-A6AA-7D330D1696CEQ48125754-2B353ECF-9E4B-4AAC-88BE-0864D9EE5432Q48307140-FEB424D5-2309-477F-9D78-F54FFAF85C4AQ52982100-3A1C2F11-61F1-4DDC-A89C-6285554D0709Q53091492-4C3844CE-C833-47F2-B4A6-3665769B75ACQ55255695-2B03FA4E-EFE5-4DF9-A098-9F57E9E3F37BQ57112512-E0C8DB74-8E1A-434F-83B4-1D6B10449AD8Q57112525-C2781E9E-31BD-4557-B516-6FDDC2B86757
P2860
Intensity-modulated radiation therapy: supportive data for prostate cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Intensity-modulated radiation therapy: supportive data for prostate cancer.
@ast
Intensity-modulated radiation therapy: supportive data for prostate cancer.
@en
type
label
Intensity-modulated radiation therapy: supportive data for prostate cancer.
@ast
Intensity-modulated radiation therapy: supportive data for prostate cancer.
@en
prefLabel
Intensity-modulated radiation therapy: supportive data for prostate cancer.
@ast
Intensity-modulated radiation therapy: supportive data for prostate cancer.
@en
P1476
Intensity-modulated radiation therapy: supportive data for prostate cancer.
@en
P2093
Oren Cahlon
P356
10.1016/J.SEMRADONC.2007.09.007
P577
2008-01-01T00:00:00Z